TAIWAN · TWSE / TPEx
CHC
承業醫 · 4164 · TWSE (main board) · Biotech and medical
Share price, 2026-10-19NT$27.301 month +7.5% · 1 year -39.1%
Directors and supervisors hold17,264,1368.8% of shares issued
Of which pledged39.0%6,740,000
Major shareholders (10%+) hold6,426,1513.3% of shares issued
Revenue, 2026-09-4.1%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 李典穎 | Chairman | 9,613,985 | 10,818,985 | 5.54% | 3,610,000 | 22,000 |
| 李沛霖 | Vice chairman · Major shareholder (10%+) | 6,426,151 | 6,426,151 | 3.29% | 3,130,000 | 32,121,791 |
| 謝渙發 | Director | — | 0 | — | — | — |
| 周宜宏 | Director | 13,000 | 19,000 | 0.01% | — | 51,551 |
| 林義夫 | Independent director | — | 0 | — | — | — |
| 池集 | Independent director | — | 0 | — | — | — |
| 高明亮 | Independent director | — | 0 | — | — | — |
| 李明倫 | President | — | 9,750 | 0.00% | — | — |
| 陳怡君 | Vice president · Chief financial officer · Chief accountant | — | 20,000 | 0.01% | — | — |